SAN DIEGO, Jan. 26 /PRNewswire-FirstCall/ -- Favrille, Inc. , a biopharmaceutical company developing patient-specific immunotherapies for the treatment of cancer, announced today that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, February 9, 2006 to discuss the Company’s fourth quarter and year end 2005 financial results. John P. Longenecker, Ph.D., President and Chief Executive Officer of Favrille, will also present an update on the Company. A press release reporting Favrille’s fourth quarter and year end financial results will be issued before the U.S. stock markets open on Thursday, February 9, 2006.
The conference call will be webcast simultaneously over the Internet. Please visit the Investor Relations section of Favrille’s corporate web site at www.favrille.com. Alternatively, callers may participate in the conference call by dialing (800) 901-5241 or (617) 786-2963, passcode 53758192. A telephone replay of the call will also be available for 48 hours. The telephone replay can be accessed by dialing (888) 286-8010 or (617) 801-6888, passcode 19070214.
About Favrille, Inc.
Favrille, Inc. is a biopharmaceutical company focused on the research, development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system. The Company’s lead product candidate, FavId, is based upon unique genetic information extracted from a patient’s tumor. FavId is currently under investigation in a pivotal Phase 3 clinical trial for patients with follicular B-cell NHL and Phase 2 clinical trials in other B-cell NHL indications. The Company is developing additional applications based on its immunotherapy expertise and proprietary cost-effective manufacturing technology, including a second product candidate, FAV-201, for the treatment of T-cell lymphoma.
Favrille, Inc.
CONTACT: Pete De Spain, Associate Director, Investor Relations & CorporateCommunications of Favrille, Inc., +1-858-526-2426, pdespain@favrille.com
Web site: http://www.favrille.com/
